BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29580046)

  • 1. Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma.
    Yu JI; Yoo GS; Cho S; Jung SH; Han Y; Park S; Lee B; Kang W; Sinn DH; Paik YH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Park HC
    Radiat Oncol J; 2018 Mar; 36(1):25-34. PubMed ID: 29580046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton beam radiotherapy combined with anti-PD1/PDL1 immune checkpoint inhibitors for advanced hepatocellular carcinoma.
    Su CW; Hou MM; Huang PW; Chou YC; Huang BS; Tseng JH; Hsu CW; Chang TC; Lin SM; Lin CC
    Am J Cancer Res; 2022; 12(4):1606-1620. PubMed ID: 35530291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I dose-escalation study of proton beam therapy for inoperable hepatocellular carcinoma.
    Kim TH; Park JW; Kim YJ; Kim BH; Woo SM; Moon SH; Kim SS; Koh YH; Lee WJ; Park SJ; Kim JY; Kim DY; Kim CM
    Cancer Res Treat; 2015 Jan; 47(1):34-45. PubMed ID: 25381830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton beam stereotactic body radiotherapy and hypofractionated therapy with pencil beam scanning is safe and effective for advanced hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A single center experience.
    Yang AH; Urrunaga NH; Siddiqui O; Wu A; Schliep M; Mossahebi S; Shetty K; Regine WF; Molitoris JK; Lominadze Z
    J Radiosurg SBRT; 2023; 9(1):43-52. PubMed ID: 38029012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade.
    Kim TH; Kim BH; Park JW; Cho YR; Koh YH; Chun JW; Oh ES; Lee DY; Lee SU; Suh YG; Woo SM; Moon SH; Kim SS; Lee WJ
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma.
    Kim TH; Park JW; Kim BH; Oh ES; Youn SH; Moon SH; Kim SS; Woo SM; Koh YH; Lee WJ; Kim DY
    Front Oncol; 2020; 10():542. PubMed ID: 32411594
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of hepatic toxicity in small liver tumors after photon or proton therapy based on factors predicting the benefits of proton.
    Uchinami Y; Katoh N; Abo D; Morita R; Taguchi H; Fujita Y; Kanehira T; Suzuki R; Miyamoto N; Takao S; Matsuura T; Sho T; Ogawa K; Orimo T; Kakisaka T; Kobashi K; Aoyama H
    Br J Radiol; 2023 Mar; 96(1144):20220720. PubMed ID: 36633335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma.
    Kim TH; Park JW; Kim BH; Kim DY; Moon SH; Kim SS; Lee JH; Woo SM; Koh YH; Lee WJ; Kim CM
    Oncotarget; 2018 Jan; 9(3):4034-4043. PubMed ID: 29423102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
    Hsieh CE; Venkatesulu BP; Lee CH; Hung SP; Wong PF; Aithala SP; Kim BK; Rao A; Tung-Chieh Chang J; Tsang NM; Wang CC; Lee CC; Lin CC; Tseng JH; Chou WC; Wang YC; Krishnan S; Hong JH
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):73-86. PubMed ID: 30797890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.
    Iizumi T; Okumura T; Sekino Y; Takahashi H; Tsai YL; Takizawa D; Ishida T; Hiroshima Y; Nakamura M; Shimizu S; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
    J Radiat Res; 2021 Jul; 62(4):682-687. PubMed ID: 34036362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness.
    Lin SY; Chen CM; Huang BS; Lai YC; Pan KT; Lin SM; Chu SY; Tseng JH
    PLoS One; 2021; 16(3):e0249003. PubMed ID: 33755701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter?
    Yoo GS; Yu JI; Park HC; Hyun D; Jeong WK; Lim HY; Choi MS; Ha SY
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton Beam Therapy for Multifocal Hepatocellular Carcinoma (HCC) Showing Complete Response in Pathological Anatomy After Liver Transplantation.
    Li Y; Shimizu S; Mizumoto M; Iizumi T; Numajiri H; Makishima H; Li G; Sakurai H
    Cureus; 2022 Jun; 14(6):e25744. PubMed ID: 35812555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALBI and P-ALBI grade in Child-Pugh A patients treated with drug eluting embolic chemoembolization for hepatocellular carcinoma.
    Carling U; Røsok B; Line PD; Dorenberg EJ
    Acta Radiol; 2019 Jun; 60(6):702-709. PubMed ID: 30205701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapy.
    Mizumoto M; Oshiro Y; Okumura T; Fukuda K; Fukumitsu N; Abei M; Ishikawa H; Ohnishi K; Numajiri H; Tsuboi K; Sakurai H
    Radiother Oncol; 2014 Oct; 113(1):54-9. PubMed ID: 25248924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic ablative radiation therapy prior to liver transplantation in hepatocellular carcinoma.
    Guarneri A; Franco P; Romagnoli R; Trino E; Mirabella S; Molinaro L; Rizza G; Filippi AR; Carucci P; Salizzoni M; Ricardi U
    Radiol Med; 2016 Nov; 121(11):873-881. PubMed ID: 27447803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three cases of hepatocellular carcinoma treated 4 times with proton beams.
    Murakami M; Fukumitsu N; Okumura T; Numajiri H; Murofushi K; Ohnishi K; Mizumoto M; Ishikawa H; Tsuboi K; Sakurai H
    Mol Clin Oncol; 2020 Jan; 12(1):31-35. PubMed ID: 31814974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the outcomes between surgical resection and proton beam therapy for single primary hepatocellular carcinoma.
    Tamura S; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Murayama S; Uesaka K
    Surg Today; 2020 Apr; 50(4):369-378. PubMed ID: 31602531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives.
    Yoo GS; Yu JI; Park HC
    World J Gastroenterol; 2018 Jul; 24(28):3090-3100. PubMed ID: 30065555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton beam therapy for hepatocellular carcinoma.
    Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.